NASDAQ
Oncolytics Biotech Inc. (ONCY) has a free cash flow growth of -62.36% as of Friday, May 29, 2026. This represents a 1544.53% decrease compared to its 12-month average of 4.32%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.